These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 8262869
1. Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosis. Clemons KV, Stevens DA. J Antimicrob Chemother; 1993 Sep; 32(3):465-72. PubMed ID: 8262869 [Abstract] [Full Text] [Related]
10. Comparative studies on the efficacy of AmBisome and Fungizone in a mouse model of disseminated aspergillosis. Takemoto K, Yamamoto Y, Ueda Y, Sumita Y, Yoshida K, Niki Y. J Antimicrob Chemother; 2004 Feb; 53(2):311-7. PubMed ID: 14729753 [Abstract] [Full Text] [Related]
11. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Clemons KV, Stevens DA. Antimicrob Agents Chemother; 1997 Sep; 41(9):2026-8. PubMed ID: 9303408 [Abstract] [Full Text] [Related]
12. Evaluation of antifungal pharmacodynamic characteristics of AmBisome against Candida albicans. Takemoto K, Yamamoto Y, Ueda Y. Microbiol Immunol; 2006 Sep; 50(8):579-86. PubMed ID: 16924142 [Abstract] [Full Text] [Related]
13. Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis. Garcia A, Adler-Moore JP, Proffitt RT. Antimicrob Agents Chemother; 2000 Sep; 44(9):2327-32. PubMed ID: 10952575 [Abstract] [Full Text] [Related]
14. Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent. Sugar AM, Picard M, Noble L. Antimicrob Agents Chemother; 1990 May; 34(5):896-8. PubMed ID: 2360825 [Abstract] [Full Text] [Related]
15. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Sugar AM, Liu XP. Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494 [Abstract] [Full Text] [Related]
16. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats. Ruijgrok EJ, Vulto AG, Van Etten EW. J Pharm Pharmacol; 2000 Jun; 52(6):619-27. PubMed ID: 10875537 [Abstract] [Full Text] [Related]
18. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. Proffitt RT, Satorius A, Chiang SM, Sullivan L, Adler-Moore JP. J Antimicrob Chemother; 1991 Oct; 28 Suppl B():49-61. PubMed ID: 1778892 [Abstract] [Full Text] [Related]
19. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response. Becker MJ, de Marie S, Fens MH, Hop WC, Verbrugh HA, Bakker-Woudenberg IA. J Antimicrob Chemother; 2002 May; 49(5):813-20. PubMed ID: 12003976 [Abstract] [Full Text] [Related]
20. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. van Etten EW, van den Heuvel-de Groot C, Bakker-Woudenberg IA. J Antimicrob Chemother; 1993 Nov; 32(5):723-39. PubMed ID: 8125837 [Abstract] [Full Text] [Related] Page: [Next] [New Search]